ReviewPharmacoEconomics2019

Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.

Lindsay Claxton et al.PubMed ↗Publisher ↗

No numbers read from the abstract.